This issue examines the claims for some of the products launched since the end of last year, and discusses the data upon which they are based. We will be reviewing some of these drugs in more detail later.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.